Getty Images
(HealthDay News) — Among adults with advanced type 2 diabetes (T2D) who are treated with insulin, willingness to participate in intensive lifestyle intervention (ILI) is very low, according to a study published online June 5. Diabetes, Obesity, and Metabolism.
Cathy J. Sun, MD, of The Ottawa Hospital in Ontario, and colleagues designed an ILI pilot project targeting adults with type 2 diabetes who had been treated with insulin for 5 or more years and had a BMI between 27 and 45 kg/m .2The intervention is a 24-week ILI consisting of three phases: 4 weeks of negative energy balance of 800 calories per day, 4 weeks of negative energy balance of 500 calories per day, and 16 weeks of daily neutral energy balance. Patients will have on-call privileges to the study physician and monitoring of medication administration for the duration of the study.
The researchers found that 83 of 555 patients screened (15.0%) met the inclusion criteria and were contacted by the research assistant. Only two patients (0.4%) were potentially interested: one had long-term travel plans and the other did not want to participate. Eighty-one patients refused to participate for reasons including that the initial diet restricted daily calories too much, that the intervention was too harsh and interfered with social life, and that multiple medications needed to be adjusted. The perception that the intervention was too harsh was the main reason for refusal to participate.
“The optimal approach and support for ILI in insulin-treated patients with type 2 diabetes remains to be established,” the authors write.
Abstract/Full text (subscription or payment may be required)
